274 related articles for article (PubMed ID: 25585877)
1. The relationship between CCR6 and its binding partners: does the CCR6-CCL20 axis have to be extended?
Lee AY; Phan TK; Hulett MD; Körner H
Cytokine; 2015 Mar; 72(1):97-101. PubMed ID: 25585877
[TBL] [Abstract][Full Text] [Related]
2. CCR6/CCL20 chemokine axis in human immunodeficiency virus immunity and pathogenesis.
Lee AYS; Körner H
J Gen Virol; 2017 Mar; 98(3):338-344. PubMed ID: 28005525
[TBL] [Abstract][Full Text] [Related]
3. Structural basis for chemokine receptor CCR6 activation by the endogenous protein ligand CCL20.
Wasilko DJ; Johnson ZL; Ammirati M; Che Y; Griffor MC; Han S; Wu H
Nat Commun; 2020 Jun; 11(1):3031. PubMed ID: 32541785
[TBL] [Abstract][Full Text] [Related]
4. Characterization and expression analysis of two novel CCR6 chemokine receptors and their three potential ligands CCL20Ls of grouper (Epinephelus coioides) post Cryptocaryon irritans infection.
Mo ZQ; Chen RA; Li YW; Huang XZ; Li AX; Luo XC; Dan XM
Fish Shellfish Immunol; 2015 Nov; 47(1):280-8. PubMed ID: 26384847
[TBL] [Abstract][Full Text] [Related]
5. Specific binding and chemotactic activity of mBD4 and its functional orthologue hBD2 to CCR6-expressing cells.
Röhrl J; Yang D; Oppenheim JJ; Hehlgans T
J Biol Chem; 2010 Mar; 285(10):7028-34. PubMed ID: 20068036
[TBL] [Abstract][Full Text] [Related]
6. CCR6 regulation of the actin cytoskeleton orchestrates human beta defensin-2- and CCL20-mediated restitution of colonic epithelial cells.
Vongsa RA; Zimmerman NP; Dwinell MB
J Biol Chem; 2009 Apr; 284(15):10034-45. PubMed ID: 19233848
[TBL] [Abstract][Full Text] [Related]
7. Chemokine/chemokine receptor pair CCL20/CCR6 in human colorectal malignancy: An overview.
Frick VO; Rubie C; Keilholz U; Ghadjar P
World J Gastroenterol; 2016 Jan; 22(2):833-41. PubMed ID: 26811629
[TBL] [Abstract][Full Text] [Related]
8. CCL20 and β-defensin-2 induce arrest of human Th17 cells on inflamed endothelium in vitro under flow conditions.
Ghannam S; Dejou C; Pedretti N; Giot JP; Dorgham K; Boukhaddaoui H; Deleuze V; Bernard FX; Jorgensen C; Yssel H; Pène J
J Immunol; 2011 Feb; 186(3):1411-20. PubMed ID: 21178014
[TBL] [Abstract][Full Text] [Related]
9. Mutational analysis of CCL20 reveals flexibility of N-terminal amino acid composition and length.
Riutta SJ; Larsen O; Getschman AE; Rosenkilde MM; Hwang ST; Volkman BF
J Leukoc Biol; 2018 Aug; 104(2):423-434. PubMed ID: 30114340
[TBL] [Abstract][Full Text] [Related]
10. The chemokine CCL20 and its receptor CCR6 in human malignancy with focus on colorectal cancer.
Ghadjar P; Rubie C; Aebersold DM; Keilholz U
Int J Cancer; 2009 Aug; 125(4):741-5. PubMed ID: 19480006
[TBL] [Abstract][Full Text] [Related]
11. Tumor-derived CCL20 affects B16 melanoma growth in mice.
Martin-Garcia D; Silva-Vilches C; Will R; Enk AH; Lonsdorf AS
J Dermatol Sci; 2020 Jan; 97(1):57-65. PubMed ID: 31883833
[TBL] [Abstract][Full Text] [Related]
12. The CCL20 and CCR6 axis in psoriasis.
Furue K; Ito T; Tsuji G; Nakahara T; Furue M
Scand J Immunol; 2020 Mar; 91(3):e12846. PubMed ID: 31692008
[TBL] [Abstract][Full Text] [Related]
13. An immune paradox: how can the same chemokine axis regulate both immune tolerance and activation?: CCR6/CCL20: a chemokine axis balancing immunological tolerance and inflammation in autoimmune disease.
Comerford I; Bunting M; Fenix K; Haylock-Jacobs S; Litchfield W; Harata-Lee Y; Turvey M; Brazzatti J; Gregor C; Nguyen P; Kara E; McColl SR
Bioessays; 2010 Dec; 32(12):1067-76. PubMed ID: 20954179
[TBL] [Abstract][Full Text] [Related]
14. CCL20/CCR6 Signaling Regulates Bone Mass Accrual in Mice.
Doucet M; Jayaraman S; Swenson E; Tusing B; Weber KL; Kominsky SL
J Bone Miner Res; 2016 Jul; 31(7):1381-90. PubMed ID: 26890063
[TBL] [Abstract][Full Text] [Related]
15. Cloning, expression and functional characterization of chicken CCR6 and its ligand CCL20.
Munoz I; Berges M; Bonsergent C; Cormier-Aline F; Quéré P; Sibille P
Mol Immunol; 2009 Dec; 47(2-3):551-9. PubMed ID: 19850344
[TBL] [Abstract][Full Text] [Related]
16. CCL20/CCR6 promotes cell proliferation and metastasis in laryngeal cancer by activating p38 pathway.
Lu E; Su J; Zhou Y; Zhang C; Wang Y
Biomed Pharmacother; 2017 Jan; 85():486-492. PubMed ID: 27916417
[TBL] [Abstract][Full Text] [Related]
17. CC-chemokine ligand 20/macrophage inflammatory protein-3α and CC-chemokine receptor 6 are overexpressed in myeloma microenvironment related to osteolytic bone lesions.
Giuliani N; Lisignoli G; Colla S; Lazzaretti M; Storti P; Mancini C; Bonomini S; Manferdini C; Codeluppi K; Facchini A; Rizzoli V
Cancer Res; 2008 Aug; 68(16):6840-50. PubMed ID: 18703490
[TBL] [Abstract][Full Text] [Related]
18. The effects of the CCR6/CCL20 biological axis on the invasion and metastasis of hepatocellular carcinoma.
Du D; Liu Y; Qian H; Zhang B; Tang X; Zhang T; Liu W
Int J Mol Sci; 2014 Apr; 15(4):6441-52. PubMed ID: 24743888
[TBL] [Abstract][Full Text] [Related]
19. The CCR6-CCL20 axis in humoral immunity and T-B cell immunobiology.
Lee AYS; Körner H
Immunobiology; 2019 May; 224(3):449-454. PubMed ID: 30772094
[TBL] [Abstract][Full Text] [Related]
20. CCL20/CCR6 promotes the invasion and migration of thyroid cancer cells via NF-kappa B signaling-induced MMP-3 production.
Zeng W; Chang H; Ma M; Li Y
Exp Mol Pathol; 2014 Aug; 97(1):184-90. PubMed ID: 24984269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
